checkAd

     162  0 Kommentare Iterum Therapeutics Announces Transition of Michael Dunne, M.D. to Strategic Advisor and Member of the Board of Directors - Seite 3

    Investor Contact:
    Judy Matthews
    Chief Financial Officer
    312-778-6073
    IR@iterumtx.com 


     

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Iterum Therapeutics Announces Transition of Michael Dunne, M.D. to Strategic Advisor and Member of the Board of Directors - Seite 3 -Dr. Dunne resigns as Chief Scientific Officer- - Steven Aronin, M.D., Senior Vice President and Head of Clinical Development, to lead Development and Regulatory Activities- DUBLIN, Ireland and CHICAGO, Dec. 23, 2020 (GLOBE NEWSWIRE) - Iterum …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer